AliveCor QT Service vs Cardiomo

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AliveCor QT Service

by AliveCor

Cardiomo

by Cardiomo, Inc.

AI Verdict

AliveCor QT Service focuses on precise QT/QTc interval measurements from specific ECG devices to inform medication decisions, making it suitable for clinical cardiac safety assessments. Cardiomo, on the other hand, provides continuous, remote heart health monitoring via a wearable device, emphasizing early detection of various cardiovascular events and real-time alerts for broader patient management.

Choose AliveCor QT Service if…

Choose AliveCor QT Service if you are a healthcare professional needing instant, accurate QT and QTc interval measurements from 6-Lead ECGs to assess cardiac safety, particularly when prescribing or monitoring medications known to affect the QT interval. This tool is ideal for informing medication decisions and enhancing patient safety in clinical settings, including decentralized clinical trials.

View AliveCor QT Service →

Choose Cardiomo if…

Choose Cardiomo if you require continuous, remote heart health monitoring for individuals, especially for detecting cardiovascular diseases and providing timely alerts to users and caregivers. This wearable device and AI-powered platform are well-suited for ongoing oversight of vital signs and early detection of potential cardiac events, offering peace of mind for patients and their support network.

View Cardiomo →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AliveCor QT Service	Cardiomo
Pricing	Contact vendor for pricing details.	Contact for pricing
Deployment	Cloud-based (Software as a Medical Device). Accessed over the internet.	Cloud-based with wearable device and mobile app
FDA Status	1 AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiomo

Cardiomo appears to have a slight edge in usability due to its focus on continuous, comfortable, and remote monitoring via a wearable patch and mobile app, which is designed for ease of use by patients and caregivers. AliveCor QT Service, while also user-friendly with its 6-lead device and app, is primarily for prescription use by healthcare professionals and focuses on point-of-care measurements, which might imply a slightly less 'set-it-and-forget-it' user experience for the end-user.

Clinical Value

AliveCor QT Service

AliveCor QT Service demonstrates strong clinical value through its FDA clearance for QT and QTc interval measurements, which are critical for cardiac safety and medication prescribing decisions. It has been validated in studies against 12-lead ECGs and is recommended by NICE for use in psychiatric services. Cardiomo, while also medical-grade and AI-powered for disease detection, is still undergoing FDA approval and its clinical validation studies are not as extensively detailed in the provided information.

Pricing & Value

Tie

Both tools require contacting the vendor for current pricing details, making a direct comparison of cost-effectiveness difficult. While Cardiomo previously had public pricing, it is no longer available, and AliveCor's pricing for its professional service is not transparent. Therefore, it's a tie in this dimension due to a lack of comparable information.

Enterprise Readiness

AliveCor QT Service

AliveCor QT Service appears more enterprise-ready with its established API for integration with EHR, SDK, CRM, EDC, and PSP platforms, and its existing use in clinical workflows. Cardiomo, while offering HIPAA-compliant cloud analytics and real-time alerts to caregivers, does not explicitly detail the same breadth of enterprise-level integration capabilities.

Innovation

Tie

Both tools demonstrate significant innovation in their respective areas. AliveCor leverages AI and deep neural networks for instant, accurate QT measurements from a 6-lead ECG, addressing a critical need in medication safety. Cardiomo offers a medical-grade wearable with continuous vital sign monitoring and AI-powered disease detection, including fall detection and predictive capabilities. Both are pushing boundaries in cardiac AI and remote monitoring.

Support & Docs

AliveCor QT Service

AliveCor provides readily accessible support information, including FAQs, user manuals, and direct contact details for customer service via phone and email. While Cardiomo mentions a user manual and contact information, the extent and accessibility of its support documentation are not as clearly outlined as AliveCor's.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AliveCor QT Service	Cardiomo
Name	AliveCor QT Service	Cardiomo
Company	AliveCor	Cardiomo, Inc.
Description	A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions.	Cardiomo offers a medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts to users and caregivers.
Key Features	Cloud-based Software as a Medical Device (SaMD), Measures QT and QTc intervals (Bazett's and Fridericia's formulas), Analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L), Prescription (Rx) use only, for qualified healthcare professionals, Utilizes AI and deep neural networks for ECG analysis, Provides instant QT measurements (as InstantQT), Integrates with KardiaStation app and KardiaPro portal, API available for integration with EHR, SDK, CRM, EDC, and PSP platforms	Medical-grade wearable patch, Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature), AI-powered disease detection (arrhythmias, cardiovascular events), Real-time alerts and notifications, Mobile application (Android and iOS), HIPAA-compliant cloud analytics, Fall detection, Long battery life (up to 7-10 days)
Categories	Cardiology AI, Pharmacology & Dosing AI	Cardiology AI, Wearables & Remote Monitoring (RPM)

Videos

Demos, reviews, and walkthroughs featuring AliveCor QT Service and Cardiomo.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems for a cardiology practice?

AliveCor QT Service integrates with EHR systems and cardiac information management systems like GE Healthcare's MUSEu2122 NX, allowing ECGs to be automatically pulled into the EHR. It also offers an API for integration with various platforms, including EHR, SDK, CRM, EDC, and PSP platforms, and data can be securely stored and fit into existing practice workflows through the KardiaPro web-based portal. Cardiomo, as a medical-grade wearable with a cloud-based platform, would likely integrate with EHRs through standards like HL7 FHIR or API connections, similar to other remote patient monitoring (RPM) solutions, to automatically capture vital signs and alerts into clinical workflows.

What is the accuracy and sensitivity of each tool in detecting cardiac events or QT prolongation?

AliveCor QT Service, utilizing AI and deep neural networks, has shown high accuracy in detecting QTc prolongation. Studies have indicated a sensitivity of 80% and specificity of 94.4% for detecting QTc values u2265500 ms when applied to mobile ECG tracings. The 6-lead device has a high negative predictive value of 99.8% at a QTc interval threshold of 500 milliseconds. Cardiomo's medical-grade sensors achieve 99.2% clinical accuracy, validated through studies, and its proprietary algorithms are trained to detect arrhythmias and other cardiac events. Wearable ECGs in general have demonstrated sensitivity ranging from 84% to 95% and specificity up to 93% for arrhythmia detection.

What is the learning curve for physicians and clinical staff when adopting these technologies?

AliveCor's KardiaMobile 6L device is designed for ease of use, allowing healthcare professionals to obtain an ECG in 30 seconds. Patients can also perform recordings with simple instructions, suggesting a relatively low learning curve for both staff and patients. Cardiomo is described as highly reliable, flexible, practical, and user-friendly, suggesting a straightforward learning curve for its wearable device and mobile application.

What kind of customer support and resources are available for physicians using these tools?

AliveCor provides an engaged engineering support team for integration processes and comprehensive technical documentation. They also offer customer service and support resources, including FAQs and user manuals. Cardiomo's information highlights its user-friendly nature, and while specific details on physician-focused support are not provided, the company emphasizes a new way of interacting with medical practitioners, implying support for their platform.

Beyond HIPAA, what additional security measures are in place to protect patient data?

AliveCor is certified with ISO 42001 for its Artificial Intelligence Management System (AIMS) and ISO 27001 for its Information Security Management System (ISMS), demonstrating a commitment to responsible AI management and information security. They also have HITRUST e1 Certification and complete SOC 2 Type 2 examinations with zero exceptions. Cardiomo's security program is validated by independent auditors and meets international standards like ISO 27001 for information security management and ISO 13485 for medical device quality management. They employ encryption at rest (AES-256) and in transit (TLS 1.3), role-based access control, and regular penetration testing.

Are there audit-trail features available to track access and changes to patient data within the systems?

For AliveCor, the API keys for authentication offer enhanced security, and all patient data is secured in compliance with HIPAA, which generally necessitates audit trails for data access. Cardiomo explicitly states that all access to data is logged and audited, and their security program includes regular access reviews and deprovisioning procedures. In general, HIPAA compliance requires event logging to track user activity and the ability to generate reports of each user who accesses a patient's data.

How do these tools facilitate multi-site rollouts for larger healthcare systems or practices with multiple locations?

AliveCor's cloud-based nature and API availability suggest flexibility for multi-site rollouts, allowing for seamless integration of patient ECG data into various systems. Their patient engagement solutions also support remote workflows and direct-to-patient device distribution, which can be beneficial for dispersed patient populations across multiple sites. Cardiomo's cloud-based platform and wearable device for continuous remote monitoring are inherently suited for multi-site deployments, enabling consistent patient monitoring and data analysis regardless of location. The ability to manage data across various sources like manufacturer portals, EHR systems, and mobile apps is crucial for multi-site cardiology practices.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring AliveCor QT Service or Cardiomo

Backers

Who funded each tool's parent company.

AliveCor QT Service

Cardiomo

Kamet Ventures